Outcome of prosthetic joint infections treated with debridement and retention of components

Clinical Infectious Diseases

Volumn 42, Issue 4, 2006, Pages 471-478

  Marculescu, C E ^a   Berbari, E F ^b   Hanssen, A D ^b   Steckelberg, J M ^b   Harmsen, S W ^b   Mandrekar, J N ^b   Osmon, Douglas R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; MINOCYCLINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DEBRIDEMENT; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT; COHORT STUDIES; DEBRIDEMENT; DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINT PROSTHESIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 32044443654     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499234     Document Type: Article

References (39)

1. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32:419-30.
2. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24:914-9.
3. Zimmerli W, Trampuz A, Ochsner P. Current concepts: prosthetic joint infections. N Engl J Med 2004; 351:1645-54.
4. Brause BD. Infected total knee replacement: diagnostic, therapeutic, and prophylactic considerations. Orthop Clin North Am 1982; 13: 245-9.
5. Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty. Clin Orthop 1991;273:105-12.
6. Tattevin P, Cremieux AC, Pettier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999; 29:292-5.
7. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78:512-23.
8. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection Study Group. JAMA 1998;279:1537-41.
9. Fitzgerald RH, Declan DR, Ilstrup DM, Van Scoy RE, Washington JA, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am 1977; 59:847-55.
10. Collins DN, McKenzie JM. Infections at the site of a hip implant: successful and unsuccessful management. Clin Orthop 1991; 269:9-15.
11. Giulieri S, Graber P, Ochsner P, Zimmerli W. Evaluation of an algorithm to treat hip prosthesis-associated infections in 63 consecutive patients of a single center [abstract K-1809]. In: Program and abstracts of the 42nd Interscience Conference of Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002.
12. Konig DP, Schierholz JM, Munnich U, Rutt J. Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants. Arch Orthop Trauma Surg 2001; 121:297-9.
13. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14:1251-3.
14. Soriano A, Garcia S, Ortega M, et al. Treatment of acute infection of total or partial hip arthroplasty with debridement and oral chemotherapy. Med Clin Barc 2003; 121:81-5.
15. Ilstrup DM. Statistical considerations and the science of surveillance. In: Morrey BF, ed. Reconstructive surgery of the joints. 2nd ed. Vol. 2. New York: Churchill-Livingstone, 1996:225-30.
16. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981; 245:54-63.
17. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003; 36:845-9.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
19. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972; 34:187-220.
20. Borden LS, Gearen PF. Infected total knee arthroplasty: a protocol for management. J Arthroplasty 1987; 2:27-36.
21. Murray RP, Hanssen AD. Attempted salvage on infected total hip arthroplasty [abstract]. In: Orthopedic transactions, 1992-1993; 16:672.
22. Rasul AT Jr, Tsukayama D, Gustilo RB. Effect of time of onset and depth of infection on the outcome of total knee arthroplasty infections. Clin Orthop 1991; 273:98-104.
23. Teeny SM, Dorr L, Murata G, Conaty P. Treatment of infected total knee arthroplasty.: irrigation and debridement versus two-stage reimplantation. J Arthroplasty 1990; 5:35-9.
24. Kramhoft M, Bodtker S, Carlsen A. Outcome of infected total knee arthroplasty. J Arthroplasty 1994; 9:617-21.
25. Hartman MB, Fehring TK, Jordan L, Norton HJ. Periprosthetic knee sepsis: the role of irrigation and debridement. Clin Orthop 1991; 273: 113-8.
26. Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31:99-108.
27. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998; 80:1306-13.
28. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty: risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 1990; 72:878-83.
29. Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 1991; 14:841-4.
30. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990; 72:1383-90.
31. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop 1984; 182:117-26.
32. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998; 27: 711-3.
33. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35:2611-6.
34. Chuard C, Vaudaux P, Waldvogel FA, Lew DP. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother 1993; 37:625-32.
35. Vaudaux PE, Lew DP, Waldwogel FA. Host factors predisposing to and influencing therapy of foreign body infections. In: Bisno AL, Waldwogel FA, eds. Infections associated with indwelling medical devices. 2nd ed. Washington, DC: American Society for Microbiology, 1994:1-29.
36. Chuard C, Lucet JC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991; 163:1369-73.
37. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37:1214-8.
38. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27:1247-54.
39. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.